These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6815892)

  • 21. Thymoma with hypersecretion of thymic hormone.
    Chollet P; Plagne R; Fonck Y; Chassagne J; Bétail G; Dardenne M; Bach JF
    Thymus; 1981 Dec; 3(6):321-34. PubMed ID: 6976649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One or several thymic hormones?
    Bach JF
    Recent Results Cancer Res; 1980; 75():106-9. PubMed ID: 6972070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating thymic factor, facteur thymique serique (FTS), in mycosis fungoides and Sezary syndrome.
    Safai B; Dardenne M; Incefy GS; Bach JF; Good RA
    Clin Immunol Immunopathol; 1979 Aug; 13(4):402-12. PubMed ID: 385190
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of FTS (facteur thymique serique) on thymus ultrathin sections using monoclonal antibodies.
    Auger C; Monier JC; Dardenne M; Pleau JM; Bach JF
    Immunol Lett; 1982 Oct; 5(4):213-6. PubMed ID: 6757115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique serum protein in mice with various tumors.
    Palmer WG; Orme TW; Boone CW
    J Natl Cancer Inst; 1974 Jan; 52(1):279-82. PubMed ID: 4810968
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nuclear magnetic resonance study of the interaction of zinc with thymulin].
    Laussac JP; Haran R; Dardenne M; Lefrancier P; Bach JF
    C R Acad Sci III; 1985; 301(10):471-5. PubMed ID: 3937565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating thymic hormone activity in young cancer patients.
    Consolini R; Cei B; Cini P; Bottone E; Casarosa L
    Clin Exp Immunol; 1986 Oct; 66(1):173-80. PubMed ID: 3802571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in the thymic factor level in rats with Jensen sarcoma and modification of the rate of tumor growth by administration of thymic hormone].
    Busse E; Rose H
    Z Exp Chir; 1981; 14(5):306-9. PubMed ID: 7199788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical evidences showing the presence of thymulin containing cells located in involuted thymus and in peripheral lymphoid organs.
    Folch H; Villegas JV; Leyan V; Barría M; Eller G; Esquivel P
    Biol Res; 2010; 43(3):291-8. PubMed ID: 21249300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new radioimmunoassay for the thymic peptide thymulin, and its application for measuring thymulin in blood samples.
    Safieh B; Kendall MD; Norman JC; Metreau E; Dardenne M; Bach JF; Pleau JM
    J Immunol Methods; 1990 Mar; 127(2):255-62. PubMed ID: 2313103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ability of lymphocytes treated with thymic factor to decrease lung metastasis in tumor-bearing mice.
    Cupissol D; Touraine JL; Serrou B
    Thymus; 1981 Jun; 3(1):9-16. PubMed ID: 7196610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Increase in activity of natural killer cells (NK cells) by serum thymic factor].
    Bardos P; Carnaud C; Bach JF
    C R Seances Acad Sci D; 1979 Dec; 289(16):1251-4. PubMed ID: 120779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of suppressor cells and thymic hormone function in the early and late phases of murine graft-versus-host reactions.
    Lang P; Moritz S; Savino W; Rostoker G; Dardenne M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2692-4. PubMed ID: 2978896
    [No Abstract]   [Full Text] [Related]  

  • 34. Age-dependent decline of T-cell cloning potential in mice.
    Fabris N; Muzzioli M; Mocchegiani E
    Mech Ageing Dev; 1982 Apr; 18(4):315-25. PubMed ID: 6980338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin levels, T-cell markers, mitogen responsiveness and thymic hormone activity in Turner's syndrome.
    Lorini R; Ugazio AG; Cammareri V; Larizza D; Castellazzi AM; Brugo MA; Severi F
    Thymus; 1983 Mar; 5(2):61-6. PubMed ID: 6602404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 38. Low serum thymic hormone levels in patients with acquired immunodeficiency syndrome.
    Dardenne M; Bach JF; Safai B
    N Engl J Med; 1983 Jul; 309(1):48-9. PubMed ID: 6682934
    [No Abstract]   [Full Text] [Related]  

  • 39. [Refractoriness of mouse spleen rosette-forming cells to thymus hormones during the period of early postnatal ontogeny].
    Giulling EV; Nikol'skiĭ IS; Kravchuk GP; Ovsienko VV; Khaloimova IL
    Ontogenez; 1981; 12(1):100-2. PubMed ID: 7197341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
    Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.